Launch Of Stem Cell Study For Acute Stroke Patients, UT Houston

February 16, 2009 at 8:00 am Leave a comment


A first-of-its-kind stem cell study to treat acute stroke victims is being launched by investigators at The University of Texas Medical School at Houston.





The Phase I study, funded with a pilot grant from The National Institutes of Health, will use the patients’ own stem cells. Researchers will enroll 10 patients who have just suffered a stroke and are being treated in the Emergency Center at Memorial Hermann – Texas Medical Center. Physicians will obtain permission from the patient or patient’s surrogate.





“This will be our first attempt to look at the safety of using stem cells in acute stroke patients,” said Sean I. Savitz, M.D., assistant professor of neurology at the medical school. “There’s a lot of promise behind this but we want to do it in a slow, rigorous fashion. Because we are injecting them intravenously, these cells can disperse to lots of different parts of the body and that’s why we’re looking at safety parameters.”





Stroke occurs when blood flow to the brain is interrupted by a blockage or a rupture in an artery, depriving brain tissue of oxygen. It is the third-leading cause of death behind heart disease and cancer. According to the American Stroke Association, nearly 800,000 Americans suffer a stroke each year – one every 40 seconds. On average, someone dies of stroke every three to four minutes.





The stem cells will be harvested from the bone marrow in the iliac crest of the leg, then separated and returned to the patient within three to six hours. Because they are the patient’s own stem cells, rejection is not expected to be an issue.





“This study is the critical first step in translating laboratory work with stem cells into benefit for patients. If effective, this treatment could be helpful to a huge segment of stroke patients to reduce their disability,” said James C. Grotta, M.D., Roy M. and Phyllis Gough Huffington Distinguished Professor of Neurology and chair of the Department of Neurology at the medical school. “We are fortunate here at UT Houston and the Texas Medical Center to have the resources needed to carry out this work, and to have attracted someone of Dr. Savitz’s caliber to lead this study.”





The clinical study builds on laboratory and animal research indicating that stem cells from bone marrow can migrate to the injured area of the brain and help repair the damage.





“Animal studies have shown that when you administer stem cells after stroke, the cells enhance the healing. We know that stem cells have some kind of guidance system and migrate to the area of injury,” Savitz said. “They’re not making new brain cells but they may be enhancing the repair processes and reducing damage.”





A UT Medical School study involving acute brain-injured children using their own stem cells has been underway since 2006 at Children’s Memorial Hermann Hospital. Principal investigator of the study is Charles Cox, M.D., The Children’s Fund, Inc. Distinguished Professor in Pediatric Surgery and Trauma at the medical school. Co-investigator is James Baumgartner, M.D., research collaborator with the medical school and a pediatric neurosurgeon at Children’s Memorial Hermann Hospital.





“It’s beneficial for this study that we have precedence. Dr. Cox and Dr. Baumgartner have been great in guiding me. That study has served as a model for us,” Savitz said.





—————————-

Article adapted by Medical News Today from original press release.

—————————-





Enrollment will begin mid-February. The study is only open to patients who are admitted to the Emergency Center at Memorial Hermann – TMC with symptoms of an immediate stroke.





Source: Deborah Mann Lake


University of Texas Health Science Center at Houston

[Via http://www.medicalnewstoday.com]

Advertisements

Entry filed under: Uncategorized.

Britain’s Control Orders And Detention Regime Cause Devastating Impact On Families, Report Reveals VGX Pharmaceuticals Announces Filing Of Device Master File Amendment With The FDA For CELLECTRA Device – Intradermal Electroporation (ID-EP)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Archives

Blog Stats

  • 15,550 hits

%d bloggers like this: